Ceftolozane Sulfate; Tazobactam Sodium Global Patent Coverage & Expiry Overview

Track protection status across key markets to assess launch feasibility.

Start your free 7-Day Trial! Book a demo to explore our global patent data.

It is formulated by 1 pharmaceutical company such as CUBIST PHARMS LLC. It is marketed under 1 brand name, including ZERBAXA. Available in 1 different strength, such as EQ 1GM BASE/VIAL;EQ 0.5GM BASE/VIAL, and administered through 1 route including POWDER;INTRAVENOUS.

Strategic Dashboard

info

insightsStrategic Insights

Sourcing & Feasibility

check_circle API availability: autorenew Loading API feasibility...

groups Licensing: 1 potential partners

calendar_todayUS Launch window: autorenew Loading launch window...

timeline Key Patent Barrier & Expiry Timeline

autorenew Loading patent barriers...

factoryGeneric Manufacturer Snapshot

autorenew Loading manufacturers...

gavelRisk & Opportunity Summary

dangerous Risk: autorenew Loading risk analysis...
watch_later Watch: autorenew Loading watch analysis...
rocket_launch Opportunity: autorenew Loading opportunity analysis...
flag
gavel
calendar_today
calendar_today

Access Global Patent Data

Stay ahead with worldwide patent expiry and latest updates.

✓ Comprehensive global patent expiry timelines
✓ Full patent family details and status updates
Unlock Global Patents

Orange Book Drug Approval Timeline

FDA approval history for this ingredient

NDA (New Drug Application) ANDA (Generic Application)

Access Global Exclusivity and Patent Expiry Extensions

Stay ahead with worldwide patent expiry insights, exclusivity data, and latest updates.

✓ Comprehensive global patent expiry timelines
✓ Full patent family details and status updates
✓ Latest exclusivity data and extensions
Unlock Global Access

US Orange Book Patents Expiration Timeline

Key expiration dates for US patents covering this ingredient

View Global Patents Expiration Timeline

Stay ahead with worldwide patent expiry insights, market data, and research updates.

✓ Comprehensive global patent expiry timelines
✓ Full patent family details and status updates
Unlock Global Patent Timeline

Orange Book Drug Strengths

Latest drug strengths approved by FDA

Strength Route of Administration Companies Latest Approval Date

Orange Book Patents

Patents approved by the FDA for the ingredient

Patent Number Publication Date Legal Status Patent Expiry Date
{"application_id":"68700","ingredient":"CEFTOLOZANE SULFATE; TAZOBACTAM SODIUM","trade_name":"ZERBAXA","family_id":"6b94fe8dbc8a45cfb125","publication_number":"US7129232B2","cleaned_patent_number":"7129232","drug_product_flag":"Y","drug_substance_flag":"Y","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2028-05-15","publication_date":"2006-10-31","legal_status":"Patented case"} US7129232B2 Molecular Formulation 31 Oct, 2006 Patented case 15 May, 2028
{"application_id":"68728","ingredient":"CEFTOLOZANE SULFATE; TAZOBACTAM SODIUM","trade_name":"ZERBAXA","family_id":"c4b9d8b2c3e1454d98a5","publication_number":"US9724353B2","cleaned_patent_number":"9724353","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2032-09-07","publication_date":"2017-08-08","legal_status":"Granted"} US9724353B2 08 Aug, 2017 Granted 07 Sep, 2032
{"application_id":"68738","ingredient":"CEFTOLOZANE SULFATE; TAZOBACTAM SODIUM","trade_name":"ZERBAXA","family_id":"c4b9d8b2c3e1454d98a5","publication_number":"US10028963B2","cleaned_patent_number":"10028963","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2032-09-07","publication_date":"2018-07-24","legal_status":"Granted"} US10028963B2 24 Jul, 2018 Granted 07 Sep, 2032
{"application_id":"68725","ingredient":"CEFTOLOZANE SULFATE; TAZOBACTAM SODIUM","trade_name":"ZERBAXA","family_id":"93611f71b8a94489852a","publication_number":"US8476425B1","cleaned_patent_number":"8476425","drug_product_flag":"-","drug_substance_flag":"Y","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2032-09-27","publication_date":"2013-07-02","legal_status":"Granted"} US8476425B2 Molecular 02 Jul, 2013 Granted 27 Sep, 2032
{"application_id":"68724","ingredient":"CEFTOLOZANE SULFATE; TAZOBACTAM SODIUM","trade_name":"ZERBAXA","family_id":"93611f71b8a94489852a","publication_number":"US8685957B1","cleaned_patent_number":"8685957","drug_product_flag":"-","drug_substance_flag":"Y","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2032-09-27","publication_date":"2014-04-01","legal_status":"Granted"} US8685957B2 Molecular 01 Apr, 2014 Granted 27 Sep, 2032
{"application_id":"7300","ingredient":"CEFTOLOZANE SULFATE; TAZOBACTAM SODIUM","trade_name":"ZERBAXA","family_id":"2d95aa3cb27c4030a2fd","publication_number":"US8968753B2","cleaned_patent_number":"8968753","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-03-14","publication_date":"2015-03-03","legal_status":"Granted"} US8968753B2 03 Mar, 2015 Granted 14 Mar, 2034
{"application_id":"7325","ingredient":"CEFTOLOZANE SULFATE; TAZOBACTAM SODIUM","trade_name":"ZERBAXA","family_id":"2d95aa3cb27c4030a2fd","publication_number":"US10420841B2","cleaned_patent_number":"10420841","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-03-14","publication_date":"2019-09-24","legal_status":"Granted"} US10420841B2 24 Sep, 2019 Granted 14 Mar, 2034
{"application_id":"7317","ingredient":"CEFTOLOZANE SULFATE; TAZOBACTAM SODIUM","trade_name":"ZERBAXA","family_id":"2d95aa3cb27c4030a2fd","publication_number":"US9320740B2","cleaned_patent_number":"9320740","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-03-14","publication_date":"2016-04-26","legal_status":"Granted"} US9320740B2 Formulation 26 Apr, 2016 Granted 14 Mar, 2034
{"application_id":"7302","ingredient":"CEFTOLOZANE SULFATE; TAZOBACTAM SODIUM","trade_name":"ZERBAXA","family_id":"2d95aa3cb27c4030a2fd","publication_number":"US9872906B2","cleaned_patent_number":"9872906","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-03-14","publication_date":"2018-01-23","legal_status":"Granted"} US9872906B2 Formulation 23 Jan, 2018 Granted 14 Mar, 2034
{"application_id":"7301","ingredient":"CEFTOLOZANE SULFATE; TAZOBACTAM SODIUM","trade_name":"ZERBAXA","family_id":"2d95aa3cb27c4030a2fd","publication_number":"US11278622B2","cleaned_patent_number":"11278622","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-03-14","publication_date":"2022-03-22","legal_status":"Granted"} US11278622B2 22 Mar, 2022 Granted 14 Mar, 2034
{"application_id":"8065","ingredient":"CEFTOLOZANE SULFATE; TAZOBACTAM SODIUM","trade_name":"ZERBAXA","family_id":"deff947cf1b34fa583cd","publication_number":"US8906898B1","cleaned_patent_number":"8906898","drug_product_flag":"Y","drug_substance_flag":"Y","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-05-28","publication_date":"2014-12-09","legal_status":"Granted"} US8906898B2 Molecular Formulation 09 Dec, 2014 Granted 28 May, 2034
{"application_id":"68745","ingredient":"CEFTOLOZANE SULFATE; TAZOBACTAM SODIUM","trade_name":"ZERBAXA","family_id":"4670480447aa4b97b013","publication_number":"US10376496B2","cleaned_patent_number":"10376496","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-09-09","publication_date":"2019-08-13","legal_status":"Granted"} US10376496B2 13 Aug, 2019 Granted 09 Sep, 2034
{"application_id":"68752","ingredient":"CEFTOLOZANE SULFATE; TAZOBACTAM SODIUM","trade_name":"ZERBAXA","family_id":"4670480447aa4b97b013","publication_number":"US10933053B2","cleaned_patent_number":"10933053","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2034-09-09","publication_date":"2021-03-02","legal_status":"Granted"} US10933053B2 02 Mar, 2021 Granted 09 Sep, 2034
{"application_id":"8479","ingredient":"CEFTOLOZANE SULFATE; TAZOBACTAM SODIUM","trade_name":"ZERBAXA","family_id":"3aa65a0daa4649d08c09","publication_number":"US10125149B2","cleaned_patent_number":"10125149","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2035-08-14","publication_date":"2018-11-13","legal_status":"Granted"} US10125149B2 Formulation 13 Nov, 2018 Granted 14 Aug, 2035

Recent Clinical Trials

Latest clinical trials and research studies for this ingredient

NCT ID Title Status Phase Conditions Start Date Completion Date

API Suppliers/Manufacturer (Branded/Generic companies)

Manufacturing Locations

View Complete Supplier List

Unlock access to all suppliers of Ceftolozane Sulfate; Tazobactam Sodium

✓ Access a comprehensive list of global suppliers
✓ Get information on each supplier
Unlock Suppliers

Note: Patent expirations and exclusivity timelines are dynamic and may shift based on litigation, regulatory extensions, and maintenance filings. Regular monitoring is advised.

GreyB © 2025 Elixir. All rights reserved.